Swedish Orphan Biovitrum AB (publ) B6E-FF:Frankfurt Stock Exchange

RT Quote | Exchange | EUR
Last | 5:29 PM EST
13.80quote price arrow up+0.29 (+2.19%)
52 week range
13.49 - 17.11

...

Loading . . .

KEY STATS

  • Open13.56
  • Day High13.80
  • Day Low13.49
  • Prev Close13.50
  • 52 Week High17.11
  • 52 Week High Date01/04/21
  • 52 Week Low13.49
  • 52 Week Low Date03/01/21
  • Market Cap4,855.01M
  • Shares Out294.9M
  • 10 Day Average Volume951.18
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-7.79

RATIOS/PROFITABILITY

  • EPS (TTM)1.10
  • P/E (TTM)12.54
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Swedish Orphan Biovitrum AB (publ) News

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Swedish Orphan Biovitrum publ AB is a Sweden-based pharmaceutical company. The Company develops, manufactures and sells medications within hemophilia, autoimmune diseases, metabolic diseases and cancer supportive care. The Company’s product portfolio is divided into three business segments: the Core Products segment offers pharmaceuticals within Inflammation area, and Genetics and metabolic therapeutic area; the Partner Products segment offers about 40 pharmaceuticals within...
Hakan Bjorklund Ph.D.
Chairman
Guido Oelkers
President
Henrik Stenqvist
Chief Financial Officer
Anne De Jonge Schuermans Ph.D.
Chief Technology Officer
Torbjorn Hallberg
General Counsel
Address
Tomtebodavagen 23A
Solna
112 76
Sweden